Literature DB >> 11240371

Oxidases and reductases are involved in metronidazole sensitivity in Helicobacter pylori.

M A Trend1, M A Jorgensen, S L Hazell, G L Mendz.   

Abstract

Helicobacter pylori is a contributing factor to the development of gastric and duodenal ulcers and some gastric cancers. Some therapeutic regimes comprise of a number of components, one of which is the antimicrobial metronidazole. A problem with these therapies is the increasing prevalence of metronidazole-resistant (MtrR) H. pylori strains. Several resistance mechanisms have been proposed, and this study addresses the 'scavenging of oxygen' hypothesis. Spectrophotometric assays of cytosolic fractions indicated that metronidazole-sensitive (MtrS) H. pylori isolates had 2.6-fold greater nicotinamide adenine dinucleotide (NADH) oxidase activity, 34-fold greater NADH nitroreductase activity, and eightfold greater nicotinamide adenine dinucleotide phosphate (NADPH) nitroreductase activity than cytosolic fractions from matched MtrR strains. Electrophoresis of cytosolic fractions in non-denaturing gels showed up to 10 protein bands when stained with Coomassie blue. Activity staining of non-denaturing, non-reducing polyacrylamide gels detected NAD(P)H oxidase, disulphide reductase, tetrazolium reductase and nitroreductase activities in the protein bands. Oxidase and reductase activities observed in a band from MtrS strains were absent in the corresponding band from MtrR strains. This band comprised at least 13 proteins, and the major constituent was identified as an alkyl hydroperoxide reductase AhpC subunit. The absence of oxidase and reductase activities in the band from MtrR strains indicated a correlation between the activity of the proteins in this band and the metronidazole-sensitive phenotype.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11240371     DOI: 10.1016/s1357-2725(00)00085-6

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  7 in total

1.  Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for Helicobacter pylori Infection in the Dominican Republic.

Authors:  Muhammad Miftahussurur; Modesto Cruz; Phawinee Subsomwong; José A Jiménez Abreu; Celso Hosking; Hiroyuki Nagashima; Junko Akada; Yoshio Yamaoka
Journal:  Am J Trop Med Hyg       Date:  2017-02-13       Impact factor: 2.345

2.  Who's Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pylori.

Authors:  Kathleen R Jones; Jeong-Heon Cha; D Scott Merrell
Journal:  Curr Drug ther       Date:  2008-09-01

3.  Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli.

Authors:  Cindy Tamae; Anne Liu; Katherine Kim; Daniel Sitz; Jeeyoon Hong; Elinne Becket; Ann Bui; Parrisa Solaimani; Katherine P Tran; Hanjing Yang; Jeffrey H Miller
Journal:  J Bacteriol       Date:  2008-07-11       Impact factor: 3.490

4.  A redox basis for metronidazole resistance in Helicobacter pylori.

Authors:  N O Kaakoush; C Asencio; F Mégraud; G L Mendz
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

Review 5.  A Comprehensive Review of Topical Odor-Controlling Treatment Options for Chronic Wounds.

Authors:  Alma Akhmetova; Timur Saliev; Iain U Allan; Matthew J Illsley; Talgat Nurgozhin; Sergey Mikhalovsky
Journal:  J Wound Ostomy Continence Nurs       Date:  2016 Nov/Dec       Impact factor: 1.741

6.  Characterization of the NAD(P)H oxidase and metronidazole reductase activities of the RdxA nitroreductase of Helicobacter pylori.

Authors:  Igor N Olekhnovich; Avery Goodwin; Paul S Hoffman
Journal:  FEBS J       Date:  2009-05-07       Impact factor: 5.542

7.  Relative effectiveness of azithromycin in killing intracellular Porphyromonas gingivalis.

Authors:  Pin-Chuang Lai; John D Walters
Journal:  Clin Exp Dent Res       Date:  2016-02-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.